Amedisys (NASDAQ: AMED) reported Q3 EPS of $0.26, $0.11 better than the analyst estimate of $0.15. Revenue for the quarter came in at $300.3 million versus the consensus estimate of $299.26 million.

For earnings history and earnings-related data on Amedisys (AMED) click here.